Advertisement
Skip to Content

Artivion Inc AORT Stock Quote

| Rating as of

NYSE: AORT

Last close prices updated as of Jun 06, 2023, 7:00 PM EST | USD | BATS BZX Real-Time Price
  • Last Close 15.45
  • Sector Healthcare
  • Industry Medical Devices
  • Investment Style Small Blend
  • Day Range 14.88  –  15.46
  • Year Range 9.64  –  23.43
  • Market Cap 631.5256 Mil
  • Volume / Avg 170,473.0 /  147,691.7
  • Price / Sales 1.94
  • Price / Book 2.26
  • Forward Div Yield
  • Trailing Div Yield 0.17%

Morningstar‘s Stock Analysis AORT

Valuation
Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price

INVESTOR

5-Star Price

INVESTOR

Economic Moat

INVESTOR

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics AORT

Company Profile AORT

Business Description

Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company’s products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others.

Contact
1655 Roberts Boulevard North West
Kennesaw, GA, 30144
Industry Medical Devices
Employees 1,300

Our Quantitative Research team models direct competitors or comparable companies from a bottom-up perspective to find companies describing their business in a similar fashion.

Artivion Inc

XNYS: AORT

LeMaitre Vascular Inc

XNAS: LMAT

Orthofix Medical Inc

XNAS: OFIX

Edwards Lifesciences Corp

XNYS: EW
Price
15.4564.8019.7285.18
Currency
USDUSDUSDUSD
Change
+$0.50 (3.34%) −$0.12 (0.18%) +$0.04 (0.20%) −$0.76 (0.88%)
Market Cap
631.53 Mil1.44 Bil720.65 Mil51.64 Bil
Industry
Medical Devices Medical Instruments & Supplies Medical Devices Medical Devices
Sector
Healthcare
Healthcare
Healthcare
Healthcare

* Trading data in this section is delayed by at least 15 minutes.

FAQs for Artivion Inc Stock

No. AORT does not currently have a forward dividend yield.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

AORT’s market cap is 631.53 Mil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

AORT’s stock style is Small Core.
Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated.

High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.

Learn more about style.

AORT’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare AORT’s historical performance against its industry peers and the overall market.